News

Learn how and why East Indian Sandalwood Oil (EISO) is making international headlines as a unique, non-substitutable botanical drug candidate.

Santalis Pharmaceuticals Announces Notice of Allowance of a US Patent for the Use of East Indian Sandalwood Oil to Treat Clostridium Infections

Posted on

SAN ANTONIO–(MEDIA)–Santalis Pharmaceuticals, Inc. announced today the Notice of Allowance by the United States Patent Office of a patent containing nine claims covering the use of East Indian sandalwood (Santalum album) oil-containing compositions to treat Clostridium infections including Clostridium difficile (C. diff). This will be the first patent issued to Santalis Pharmaceuticals for the use of sandalwood oil to treat […]Read More Santalis Pharmaceuticals Announces Notice of Allowance of a US Patent for the Use of East Indian Sandalwood Oil to Treat Clostridium Infections